Oral contraceptives in acute viral hepatitis.
Thirty-four women took oral contraceptives during a major part, or throughout the course, of acute viral hepatitis. The acute illness and sequelae during the following year were compared to those of 34 matched control women with acute viral hepatitis who never took oral contraceptives. Statistical and clinical analysis showed no difference in severity of acute illness or frequency of sequelae. These findings suggest that oral contraceptives are not detrimental when taken during a course of acute viral hepatitis.
D000208:Acute Disease; D000328:Adult; D000410:Alanine Transaminase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D002462:Cell Membrane / Q000276:immunology; D004796:Clinical Enzyme Tests; D003276:Contraceptives, Oral / Q000008:administration & dosage; D003289:Convalescence; D005260:Female; D005500:Follow-Up Studies; D006506:Hepatitis A / Q000175:diagnosis / Q000276:immunology; D006511:Hepatitis B Antigens / Q000302:isolation & purification; D006801:Humans; D011795:Surveys and Questionnaires; D013997:Time Factors
D003276:Contraceptives, Oral; D006511:Hepatitis B Antigens; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase